Haemonetics (HAE) Free Cash Flow (2009 - 2026)

Haemonetics has reported Free Cash Flow for 18 years, with the latest figure at $44.4 million in Q2 2026.

• On a quarterly basis, Free Cash Flow rose 225.61% year-over-year to $44.4 million in Q2 2026; TTM through Jun 2026 was $291.2 million, a 53.95% increase from a year earlier, with the FY2026 full-year figure at $260.4 million, up 82.83% from the prior year.
• Free Cash Flow was $44.4 million for Q2 2026 at Haemonetics, down from $53.3 million in the prior quarter.
• The five-year high for Free Cash Flow was $106.3 million in Q3 2025, with the low at -$33.1 million in Q2 2024.
• Average Free Cash Flow over 5 years is $39.0 million, with a median of $39.4 million recorded in 2024.
• The largest YoY upside for Free Cash Flow was 526.93% in 2024 against a maximum downside of 390.02% in 2024.
• Over 5 years, Free Cash Flow stood at $47.6 million in 2022, then sank by 131.93% to -$15.2 million in 2023, then jumped by 331.92% to $35.2 million in 2024, then jumped by 147.63% to $87.2 million in 2025, then plunged by 49.07% to $44.4 million in 2026.
• The last three Free Cash Flow figures came in at $44.4 million (Q2 2026), $53.3 million (Q1 2026), and $87.2 million (Q4 2025), per Business Quant data.